Skip to content

Potential Risks from Cannabis- Infused Beverages: A Critical Review

Anna Marie Froude, Nikki Pangborn, Phillip Britz-McKibbin, James MacKillop, Iris Balodis

Cannabis November 26, 2024 DOI: 10.26828/cannabis/2024/000271

Summary

AI-generated from the abstract

Cannabis beverages, legalized in Canada in 2019, produce different acute and long-term effects than dried flower or edible products due to distinct absorption and processing in the body. A systematic review of 29 studies found that healthy, infrequent users experienced aversive subjective and physiological effects after consuming cannabis beverages. Many products also had inaccurate cannabinoid labeling, posing consumer risks. The research highlights the limited and inconsistent evidence on cannabis beverages, compounded by the wide variety of formulations, and underscores the need for more direct studies on their safety and effects.

Study at a glance

Characteristics Systematic review Peer reviewed
Key finding Cannabis beverages induce aversive acute subjective and physiological effects in healthy, infrequent users, and many products have inaccurate cannabinoid labeling.

Abstract

Although Canada legalized cannabis beverages in 2019, most available research on acute cannabis intoxication derives from dried flower and edible products. The distinct bioavailability and pharmacokinetic properties of phytocannabinoids ingested from beverages, however, contribute to significantly different acute and long-term effects that need to be better understood to ensure consumer safety. Objective: This review investigates existing cannabis beverage literature, with a particular focus on acute intoxication effects. Method: PubMed, PsycINFO and Web of Science databases were systematically searched. A structured search generated 29 eligible studies, comprising studies of consumption patterns and beliefs, advertisements and marketing, acute effects in human models, and drink composition. Results: Human studies report aversive acute subjective and physiological effects induced by cannabis beverages in healthy, infrequent users. Beverages also showed inaccurate cannabinoid labeling, posing potential risks to consumers. This review highlights the paucity and inconsistency of available research, further exacerbated by the sheer diversity of formulations investigated, while beginning to address some questions surrounding the safety and risks associated with cannabis beverages. Conclusions: Given the extensive differences in effects across cannabis-infused beverages, and the growing ‘drinkables’ market, it is essential that more studies directly examine both acute and long-term impacts of cannabis beverage consumption.

Comments

No comments yet.

Log in to comment